Table 1 Maternal and neonatal characteristics and outcomes. Numbers (%) are shown unless otherwise stated
From: Hypertriglyceridaemia in extremely preterm infants receiving parenteral lipid emulsions
Normal TG N = 157 (80.5) | HT Group N = 38 (19.5) | HT vs normal TG P value or OR (95% CI; P Value) | |
|---|---|---|---|
Multiple Gestation | 45 (28.6) | 10 (26.3) | 0.790 |
Caesarean delivery | 90 (57.3) | 28 (73.7) | 0.065 |
Chorioamnionitis | 44 (28.0) | 7 (18.4) | 0.233 |
Apgar < 7@1 min | 102 (65.0) | 28 (73.7) | 0.315 |
Apgar < 7@5 min | 45 (28.7) | 17 (44.7) | 0.064 |
Mean (SD) GA, wk | 27 (1) | 26 (2) | 0.065 |
Mean (SD) BW, g | 1017 (215) | 778 (145) | < 0.001 |
SGA | 5 (3.2) | 10 (26.3) | < 0.001 |
Male Gender | 87 (55.4) | 23 (60.5) | 0.577 |
Early Sepsis | 2 (1.3) | 1 (2.6) | 0.578 |
Acute Renal Failure | 0 | 0 | – |
Hepatic Failure | 0 | 0 | – |
Outcomes | |||
Mortality | 8 (5.1) | 6 (15.8) | 3.5 (1.13–10.76; 0.041) |
Late Sepsis | 36 (22.9) | 11 (28.9) | 1.4 (0.62–3.03; 0.441) |
PDA | 120 (76.4) | 28 (73.7) | 0.9 (0.38–1.94; 0.715) |
Grade III-IV IVH | 10 (6.4) | 5 (13.2) | 2.2 (0.71–6.95; 0.190) |
Stage III-IV ROP | 16 (10.2) | 12 (31.6) | 4.1 (1.73–9.59; 0.002) |
NEC | 7(4.5) | 5 (13.2) | 3.2 (0.97–10.86; 0.074) |
CLD | 64 (40.8) | 22 (57.9) | 1.9 (0.97–4.09; 0.061) |